Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / World/  Coronavirus vaccine: Australian vaccine safe, produces antibody response in early tests
BackBack

Coronavirus vaccine: Australian vaccine safe, produces antibody response in early tests

Drug firms are racing to develop effective treatments for coronavirus amid a surge in cases that has infected 53,090,778, killed 1,299,400 people and battered the world's ecoomy

A box of a potential vaccine against coronavirus (Representative image) (REUTERS)Premium
A box of a potential vaccine against coronavirus (Representative image) (REUTERS)

Developed by an Australian university and CSL Ltd, an early testing of a potential coronavirus vaccine has shown it to be safe and produce an antibody response, Minister for Health Greg Hunt told news agency Reuters on Friday.

Drug firms are racing to develop effective treatments for the infection amid a surge in coronavirus cases that has infected 53,090,778, killed 1,299,400 people and battered the world's economy.

Several candidates including ones produced by Pfizer and AstraZeneca are expected to imminently announce the results from final stage testing.

Covid-19 vaccine update

Earlier this week, Pfizer said that its experimental coronavirus vaccine had been more than 90% effective based on initial trial results.

Pfizer and German partner BioNTech SE have said no serious safety concerns were found so far and expect to seek US emergency use authorisation this month, raising the chance of a regulatory decision as soon as December.

While slightly behind other candidates, the vaccine candidate developed by the University of Queensland and CSL will now begin the last stage of testing, Hunt said.

"The vaccine is proving to be safe through phase I clinical trials and that it is proving to produce a positive antibody response," Hunt told reporters in Queensland.

"It is doing its job. That is particularly so in the elderly, and that is an especially important outcome, given the global vulnerability to elderly around the world from COVID-19."

Should it pass those trials, Hunt said it could be ready for distribution by the third quarter of 2021.

Australia has already agreed to buy 51 million does of the University of Queensland developed candidate. Australia will also buy the AstraZeneca vaccine too should it pass last stage testing.

With agency inputs

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 13 Nov 2020, 09:39 AM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App